BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 26349663)

  • 1. High expression levels of miR-21 and miR-210 predict unfavorable survival in breast cancer: a systemic review and meta-analysis.
    Tang Y; Zhou X; Ji J; Chen L; Cao J; Luo J; Zhang S
    Int J Biol Markers; 2015 Nov; 30(4):e347-58. PubMed ID: 26349663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High expression of miR-210 predicts poor survival in patients with breast cancer: a meta-analysis.
    Hong L; Yang J; Han Y; Lu Q; Cao J; Syed L
    Gene; 2012 Oct; 507(2):135-8. PubMed ID: 22842193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High expression of miR-21 and miR-155 predicts recurrence and unfavourable survival in non-small cell lung cancer.
    Yang M; Shen H; Qiu C; Ni Y; Wang L; Dong W; Liao Y; Du J
    Eur J Cancer; 2013 Feb; 49(3):604-15. PubMed ID: 23099007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The expression of miR-21 and miR-375 predict prognosis of esophageal cancer.
    Fu C; Dong W; Wang Z; Li H; Qin Q; Li B
    Biochem Biophys Res Commun; 2014 Apr; 446(4):1197-203. PubMed ID: 24680681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrative data mining and meta-analysis to investigate the prognostic role of microRNA-200 family in various human malignant neoplasms: A consideration on heterogeneity.
    Yuan L; Bing Z; Yan P; Li R; Wang C; Sun X; Yang J; Shi X; Zhang Y; Yang K
    Gene; 2019 Oct; 716():144025. PubMed ID: 31394177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic and clinicopathological significance of microRNA-21 overexpression in breast cancer: a meta-analysis.
    Pan F; Mao H; Deng L; Li G; Geng P
    Int J Clin Exp Pathol; 2014; 7(9):5622-33. PubMed ID: 25337203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of poor prognosis in breast cancer patients based on microRNA-21 expression: a meta-analysis.
    Wang Y; Zhang Y; Pan C; Ma F; Zhang S
    PLoS One; 2015; 10(2):e0118647. PubMed ID: 25706383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The microRNAs as prognostic biomarkers for survival in esophageal cancer: a meta-analysis.
    Fu W; Pang L; Chen Y; Yang L; Zhu J; Wei Y
    ScientificWorldJournal; 2014; 2014():523979. PubMed ID: 25097879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic Value of Expression of MicroRNAs in Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis.
    Zhan B; Lu D; Luo P; Wang B
    Clin Lab; 2016 Nov; 62(11):2203-2211. PubMed ID: 28164670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic role of microRNA-21 in colorectal cancer: a meta-analysis.
    Xia X; Yang B; Zhai X; Liu X; Shen K; Wu Z; Cai J
    PLoS One; 2013; 8(11):e80426. PubMed ID: 24265822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MiR-200 family and cancer: From a meta-analysis view.
    Huang GL; Sun J; Lu Y; Liu Y; Cao H; Zhang H; Calin GA
    Mol Aspects Med; 2019 Dec; 70():57-71. PubMed ID: 31558294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrating MicroRNA Expression Profiling Studies to Systematically Evaluate the Diagnostic Value of MicroRNAs in Pancreatic Cancer and Validate Their Prognostic Significance with the Cancer Genome Atlas Data.
    Zhang Z; Pan B; Lv S; Ji Z; Wu Q; Lang R; He Q; Zhao X
    Cell Physiol Biochem; 2018; 49(2):678-695. PubMed ID: 30165365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of low microRNA-34a expression in human gastrointestinal cancer: a systematic review and meta-analysis.
    Chen YL; Liu XL; Li L
    BMC Cancer; 2021 Jan; 21(1):63. PubMed ID: 33446130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic and clinicopathological significance of MicroRNA-153 in human cancers: A meta-analysis.
    Huang M; Li C; Kong F; Wu Y; Yuan Q; Hu L
    Medicine (Baltimore); 2020 Nov; 99(46):e22833. PubMed ID: 33181653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNAs in the prognosis of triple-negative breast cancer: A systematic review and meta-analysis.
    Lü L; Mao X; Shi P; He B; Xu K; Zhang S; Wang J
    Medicine (Baltimore); 2017 Jun; 96(22):e7085. PubMed ID: 28562579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic role of microRNA-210 in various carcinomas: a systematic review and meta-analysis.
    Li M; Ma X; Li M; Zhang B; Huang J; Liu L; Wei Y
    Dis Markers; 2014; 2014():106197. PubMed ID: 24591754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of microRNA-10b overexpression in breast cancer: a meta-analysis.
    Wang N; Chen P; Huang LP; Wang TZ
    Genet Mol Res; 2016 Apr; 15(2):. PubMed ID: 27173192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. microRNAs with prognostic significance in pancreatic ductal adenocarcinoma: A meta-analysis.
    Frampton AE; Krell J; Jamieson NB; Gall TM; Giovannetti E; Funel N; Mato Prado M; Krell D; Habib NA; Castellano L; Jiao LR; Stebbing J
    Eur J Cancer; 2015 Jul; 51(11):1389-404. PubMed ID: 26002251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic and prognostic value of miR-200 family in breast cancer: A meta-analysis and systematic review.
    Thi Chung Duong T; Nguyen THN; Thi Ngoc Nguyen T; Huynh LH; Ngo HP; Thi Nguyen H
    Cancer Epidemiol; 2022 Apr; 77():102097. PubMed ID: 35030348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miRNAs as therapeutic predictors and prognostic biomarkers of neoadjuvant chemotherapy in breast cancer: a systematic review and meta-analysis.
    Zhang Z; Zhang H; Yu J; Xu L; Pang X; Xiang Q; Liu Q; Cui Y
    Breast Cancer Res Treat; 2022 Aug; 194(3):483-505. PubMed ID: 35727379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.